equitymaster.comFalseFalseGLENMARK LIFE SCIENCES |
|
Price History |
Price | Rs | 775.3 | | % ch | % | 0.0 |
Mkt Cap | Rs m | 94,995 | | No. of
shares | m | 122.53 |
Vol | '000 | 9.0 | | % ch week | % | 4.4 |
P/E | X | 18.3 | | % ch 1-mth | % | -12.8 |
P/CF | X | 18.7 | | % ch 12-mth | % | 102.6 |
EPS (TTM) | Rs | 42.4 | | 52 week H/L | Rs | 904.2/373.3 |
(As on Mar 28, 2024 (Close)) |
|
Financials |
* Results Consolidated | No. of Months
Year Ending | 12
Mar-19* | 12
Mar-20* | 12
Mar-21* | 12
Mar-22* | 12
Mar-23* |
EQUITY SHARE DATA |
High | Rs | NA | NA | NA | 800 | 534 |
Low | Rs | NA | NA | NA | 376 | 369 |
Sales per share (Unadj.) | Rs | 4,522.6 | 7,843.4 | 1,923.6 | 173.3 | 176.4 |
Earnings per share (Unadj.) | Rs | 997.9 | 1,597.4 | 358.8 | 34.2 | 38.1 |
Diluted earnings per share | Rs | 16.0 | 25.6 | 28.7 | 34.2 | 38.1 |
Cash flow per share (Unadj.) | Rs | 1,096.2 | 1,747.3 | 392.8 | 37.3 | 41.5 |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 21.00 | 21.00 |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 21.00 | 21.00 |
Avg Dividend yield | % | 0 | 0 | 0 | 3.6 | 4.7 |
Book value per share (Unadj.) | Rs | 449.6 | 2,049.4 | 768.1 | 167.4 | 174.0 |
Adj. book value per share | Rs | 7.2 | 32.8 | 61.4 | 167.4 | 174.0 |
Shares outstanding (eoy) | m | 1.96 | 1.96 | 9.80 | 122.53 | 122.53 |
Bonus / Rights / Conversions | | 0 | 0 | 0 | 0 | 0 |
Price / Sales ratio | x | 0 | 0 | 0 | 3.4 | 2.6 |
Avg P/E ratio | x | 0 | 0 | 0 | 17.2 | 11.8 |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 15.8 | 10.9 |
Price / Book Value ratio | x | 0 | 0 | 0 | 3.5 | 2.6 |
Dividend payout | % | 0 | 0 | 0 | 61.5 | 55.1 |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 72,043 | 55,321 |
No. of employees | `000 | NA | NA | NA | NA | NA |
Total wages/salary | Rs m | 1,063 | 1,423 | 1,491 | 1,687 | 1,802 |
Avg. sales/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
Avg. wages/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
Avg. net profit/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
INCOME DATA |
Net Sales | Rs m | 8,864 | 15,373 | 18,852 | 21,232 | 21,612 |
Other income | Rs m | 10 | 120 | 8 | 147 | 290 |
Total revenues | Rs m | 8,874 | 15,493 | 18,860 | 21,379 | 21,902 |
Gross profit | Rs m | 2,472 | 4,720 | 5,911 | 6,161 | 6,423 |
Depreciation | Rs m | 193 | 294 | 334 | 379 | 421 |
Interest | Rs m | 6 | 335 | 875 | 280 | 5 |
Profit before tax | Rs m | 2,283 | 4,211 | 4,709 | 5,649 | 6,286 |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 |
Tax | Rs m | 327 | 1,080 | 1,194 | 1,462 | 1,616 |
Profit after tax | Rs m | 1,956 | 3,131 | 3,516 | 4,187 | 4,670 |
Gross profit margin | % | 27.9 | 30.7 | 31.4 | 29.0 | 29.7 |
Effective tax rate | % | 14.3 | 25.6 | 25.3 | 25.9 | 25.7 |
Net profit margin | % | 22.1 | 20.4 | 18.6 | 19.7 | 21.6 |
BALANCE SHEET DATA |
Current assets | Rs m | 9,307 | 11,601 | 16,225 | 21,274 | 23,687 |
Current liabilities | Rs m | 13,804 | 13,075 | 14,449 | 7,468 | 10,228 |
Net working cap to sales | % | -50.7 | -9.6 | 9.4 | 65.0 | 62.3 |
Current ratio | x | 0.7 | 0.9 | 1.1 | 2.8 | 2.3 |
Inventory Days | Days | 3 | 2 | 2 | 3 | 2 |
Debtors Days | Days | 185 | 152 | 120 | 116 | 136 |
Net fixed assets | Rs m | 5,447 | 5,655 | 5,980 | 7,064 | 8,518 |
Share capital | Rs m | 20 | 20 | 20 | 245 | 245 |
"Free" reserves | Rs m | 862 | 3,997 | 7,508 | 20,263 | 21,070 |
Net worth | Rs m | 881 | 4,017 | 7,527 | 20,508 | 21,315 |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 |
Total assets | Rs m | 14,754 | 17,256 | 22,206 | 28,338 | 32,205 |
Interest coverage | x | 378.4 | 13.6 | 6.4 | 21.2 | 1,150.2 |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 |
Sales to assets ratio | x | 0.6 | 0.9 | 0.8 | 0.7 | 0.7 |
Return on assets | % | 13.3 | 20.1 | 19.8 | 15.8 | 14.5 |
Return on equity | % | 221.9 | 77.9 | 46.7 | 20.4 | 21.9 |
Return on capital | % | 259.7 | 113.2 | 74.2 | 28.9 | 29.5 |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 |
Fx inflow | Rs m | 72 | 6,266 | 7,870 | 10,568 | 9,691 |
Fx outflow | Rs m | 39 | 2,924 | 3,955 | 3,883 | 5,001 |
Net fx | Rs m | 34 | 3,342 | 3,915 | 6,685 | 4,689 |
CASH FLOW |
From Operations | Rs m | 104 | 1,950 | 3,881 | 5,976 | 3,134 |
From Investments | Rs m | -89 | -505 | -687 | -1,222 | -1,541 |
From Financial Activity | Rs m | 5 | -1,366 | -2,138 | -788 | -3,876 |
Net Cashflow | Rs m | 21 | 79 | 1,056 | 3,966 | -2,283 |
* Results Consolidated | Source: Company Annual Reports, Regulatory Filings, Equitymaster |
|
Share Holding |
Indian Promoters: | 82.9% |
Foreign collaborators: | 0.0% |
Indian inst/Mut Fund: | 5.3% |
FIIs: | 4.6% |
ADR/GDR: | 0.0% |
Free float: | 17.2% |
Shareholders: | 185,531 |
Pledged promoter(s) holding: | 9.5% |
|
Company Information |
REGD OFF: | Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur - 413213 |
E-MAIL: | complianceofficer@glenmarklifesciences.com |
WEB: | www.glenmarklifesciences.com |
TELEPHONE: | 02189 234456/234246 |
FAX: | |
SECTOR: | PHARMACEUTICALS |
GROUP: | Glenmark |
TR AGENT: | K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda |
CHM: | Glenn Saldanha |
COMP SEC: | Rudalf Corriea |
YEAR OF INC: | 2011 |
BSE CODE: | 543322 |
FV (Rs): | 2 |
DIV YIELD (%): | 2.7 |